Sector portfolio · VC firm · United Kingdom
SoftBank Vision Fund's Biotech portfolio
SoftBank Vision Fund has backed 12 Biotech startups in rounds we track, $2.2B between them, shown by the stage each has reached. The best-funded is Relay Therapeutics.
SoftBank Vision Fund's whole portfolioSoftBank Vision Fund's profile
Funding by segment
- Series C and later$1.6B5
- Stage not reported$225M4
- Series B$371M3
Where they are based
- United States10$2.0B
- Netherlands1$22M
United States
NetherlandsFounded
1 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M1
- $10M to $50M1
- $50M to $250M9
- $250M to $1B1
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
11 of 12 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States10
- Netherlands1
Startups by country, 2 countries in all.
Segment by segment
Series C and later
5 startups · $1.6B raised
Relay TherapeuticsRelay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.United States$932M
Pear TherapeuticsPear Therapeutics is a Massachusetts-based prescription digital therapeutic platform that offers solutions such as clinical engageUnited States$239M
Dewpoint TherapeuticsDewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates.United States$196M
Vividion TherapeuticsWe are bringing more disease-causing targets within the reach of small molecule therapeutics to transform care for patients with dUnited States$185M
PlexiumPlexium is a biotechnology company based in San Diego, California, founded in 2018.United States$88M
Stage not reported
4 startups · $225M raised
Vir BiotechnologyVir Biotechnology is an immunology company that develops products to treat and prevent infectious diseases and other serious conditions.United States$150M
Alto PharmacyAlto is a digital pharmacy that makes the prescription experience easier.United States$50M
LUMICKSLUMICKS provides single-molecule analysis technologies for cancer research and immunotherapy.Netherlands$22M
Neumora TherapeuticsNeumora Therapeutics operates as a clinical-stage biotechnology company.United States$2.6M
Series B
3 startups · $371M raised
Repertoire Immune MedicinesRepertoire Immune Medicines is a clinical stage biotechnology company.-$189M
Variant BioVariant Bio is a biotechnology company based in Seattle, founded in 2018.United States$105M
Hexagon BioHexagon Bio is a biopharmaceutical company based in Menlo Park, California, founded in 2016.United States$77M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names SoftBank Vision Fund as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like SoftBank Vision Fund?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.